Takeda Pharmaceutical Co. said Thursday that it had suspended the use of 1.6 million doses of Moderna Inc.'s Covid-19 vaccine in Japan due to reports of contamination.
Takeda, which distributes the vaccine in Japan, said it has asked Moderna to investigate the issue reported at multiple vaccination sites.
Takeda said it hadn't received any reports of safety concerns linked to contamination.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.